INDSWIFT LABORATORIES
Back to Cashflow Statement
|
INDSWIFT LABORATORIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-186 Cr | ₹-141 Cr | ₹-124 Cr | ₹-133 Cr | ₹100 Cr |
What is the latest Cash Flow from Financing Activities ratio of INDSWIFT LABORATORIES ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2023 | ₹-186 Cr |
Mar2022 | ₹-141 Cr |
Mar2021 | ₹-124 Cr |
Mar2020 | ₹-133 Cr |
Mar2019 | ₹100 Cr |
How is Cash Flow from Financing Activities of INDSWIFT LABORATORIES Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2023 | ₹-186 Cr | Negative | |
Mar2022 | ₹-141 Cr | Negative | |
Mar2021 | ₹-124 Cr | Negative | |
Mar2020 | ₹-133 Cr | Negative | |
Mar2019 | ₹100 Cr | - |
Compare Cash Flow from Financing Activities of peers of INDSWIFT LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDSWIFT LABORATORIES | ₹662.8 Cr | -7.9% | 11% | 69.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹367,026.0 Cr | 0.5% | -5.7% | 55.1% | Stock Analytics | |
CIPLA | ₹114,925.0 Cr | 1.1% | -4.4% | 55.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹105,128.0 Cr | -0.7% | 9.4% | 21.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,109.0 Cr | 0.1% | 1.1% | 28.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹102,736.0 Cr | 6% | 2.8% | 93.1% | Stock Analytics |
INDSWIFT LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDSWIFT LABORATORIES | -7.9% |
11% |
69.5% |
SENSEX | 0.2% |
-0.2% |
20.9% |
You may also like the below Video Courses